Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sarah E Gradecki"'
Autor:
Nicole L. Edmonds, Sarah E Gradecki, Priya Katyal, Kevin T Lynch, Anne M Stowman, Alejandro A Gru, Victor H Engelhard, Craig L Slingluff, Ileana S. Mauldin
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTTertiary lymphoid structures (TLS) are ectopic lymphoid structures that can arise in human cancers and are associated with improved overall survival (OS) and response to immune checkpoint blockade (ICB) in several cancers, including non-desmo
Externí odkaz:
https://doaj.org/article/76a7c46882b34e41922abb9223121455
Publikováno v:
International Journal of Gynecological Pathology. 42:35-42
Preferentially expressed antigen in melanoma (PRAME) is a cancer testes antigen initially employed as a diagnostic marker for melanoma. Although negative in most normal tissues, its expression has been reported in benign endometrial glands. Additiona
Autor:
Ashley P, Craddock, William J, Kane, Shyam S, Raghavan, Eli S, Williams, Alejandro A, Gru, Sarah E, Gradecki
Publikováno v:
American Journal of Surgical Pathology. 46:956-962
Primary cutaneous B-cell lymphomas (PCBCLs) are diagnostically challenging entities due to significant overlap in clinical and morphologic features with reactive lymphoid proliferations. Traditional methods for evaluating clonality such as immunohist
Publikováno v:
AJSP: Reviews and Reports. 26:259-263
Publikováno v:
Journal of Cutaneous Pathology.
Autor:
Minyoung Kwak, Max O. Meneveau, Nolan A. Wages, Kevin T. Lynch, Craig L. Slingluff, Sarah E. Gradecki, Alejandro A. Gru
Publikováno v:
Am J Surg Pathol
Indoleamine 2-3 dioxygenase 1 (IDO1) expression may contribute to immunologic escape by melanoma metastases. However, a recent clinical trial failed to identify any clinical benefits of IDO1 inhibition in patients with unresectable metastatic melanom
Autor:
Sarah E. Gradecki, Alejandro A. Gru
Publikováno v:
Journal of Cutaneous Pathology. 47:617-620
Although renal cell carcinoma (RCC) is known for its propensity to metastasize widely throughout the body, cutaneous metastases are uncommon and seen in less than 3% of RCCs. A 56-year-old man presented with a painful red lesion with satellite nodule
Publikováno v:
Journal of cutaneous pathologyREFERENCES. 49(12)
Autor:
Sarah E. Gradecki, Victor E. Laubach, Mark E. Roeser, Huy Q. Ta, Aimee Zhang, J. Hunter Mehaffey, Dustin T. Money, Matthew R. Byler, Evan P. Rotar, Nathan Haywood, Irving L. Kron, Morgan Salmon
Publikováno v:
J Burn Care Res
Current burn therapy is largely supportive with limited therapies to curb secondary burn progression. Adenosine 2A receptor (A2AR) agonists have anti-inflammatory effects with decreased inflammatory cell infiltrate and release of proinflammatory medi
Publikováno v:
The American Journal of dermatopathology. 43(9)
Basal cell carcinoma (BCC) is the most common skin cancer, and it has numerous histologic mimics with variable prognoses and treatments. Although some immunohistochemical stains can be used for the differential diagnosis of BCC, variability and overl